de Azambuja E - Search Results

1

Luminal B breast cancer: molecular characterization, clinical management, and future perspectives.

Ades F, Zardavas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, Viale G, Sotiriou C, Piccart M. Ades F, et al. Among authors: de azambuja e. J Clin Oncol. 2014 Sep 1;32(25):2794-803. doi: 10.1200/JCO.2013.54.1870. Epub 2014 Jul 21. J Clin Oncol. 2014. PMID: 25049332 Review.

2

Adjuvant chemotherapy in 2005: standards and beyond.

Piccart MJ, de Valeriola D, Dal Lago L, de Azambuja E, Demonty G, Lebrun F, Bernard-Marty Ch, Colozza M, Cufer T. Piccart MJ, et al. Among authors: de valeriola d, de azambuja e. Breast. 2005 Dec;14(6):439-45. doi: 10.1016/j.breast.2005.08.004. Epub 2005 Sep 26. Breast. 2005. PMID: 16188441 Review.

3

Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation.

Lothaire P, de Azambuja E, Dequanter D, Lalami Y, Sotiriou C, Andry G, Castro G Jr, Awada A. Lothaire P, et al. Among authors: de azambuja e. Head Neck. 2006 Mar;28(3):256-69. doi: 10.1002/hed.20326. Head Neck. 2006. PMID: 16284973 Review.

4

Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era.

Colozza M, de Azambuja E, Cardoso F, Bernard C, Piccart MJ. Colozza M, et al. Among authors: de azambuja e. Oncologist. 2006 Feb;11(2):111-25. doi: 10.1634/theoncologist.11-2-111. Oncologist. 2006. PMID: 16476832 Free article. Review.

5

Achievements in systemic therapies in the pregenomic era in metastatic breast cancer.

Colozza M, de Azambuja E, Personeni N, Lebrun F, Piccart MJ, Cardoso F. Colozza M, et al. Among authors: de azambuja e. Oncologist. 2007 Mar;12(3):253-70. doi: 10.1634/theoncologist.12-3-253. Oncologist. 2007. PMID: 17405890 Free article. Review.

6

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.

de Azambuja E, Cardoso F, de Castro G Jr, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M. de Azambuja E, et al. Among authors: de castro g jr. Br J Cancer. 2007 May 21;96(10):1504-13. doi: 10.1038/sj.bjc.6603756. Epub 2007 Apr 24. Br J Cancer. 2007. PMID: 17453008 Free PMC article.

7

Molecular targeted therapies in breast cancer: where are we now?

Widakowich C, de Azambuja E, Gil T, Cardoso F, Dinh P, Awada A, Piccart-Gebhart M. Widakowich C, et al. Among authors: de azambuja e. Int J Biochem Cell Biol. 2007;39(7-8):1375-87. doi: 10.1016/j.biocel.2007.04.015. Epub 2007 May 4. Int J Biochem Cell Biol. 2007. PMID: 17543572 Review.

8

Trastuzumab for early breast cancer: current status and future directions.

Dinh P, de Azambuja E, Piccart-Gebhart MJ. Dinh P, et al. Among authors: de azambuja e. Clin Adv Hematol Oncol. 2007 Sep;5(9):707-17. Clin Adv Hematol Oncol. 2007. PMID: 17982412 Review.

9

Facts and controversies in the use of trastuzumab in the adjuvant setting.

Dinh P, de Azambuja E, Cardoso F, Piccart-Gebhart MJ. Dinh P, et al. Among authors: de azambuja e. Nat Clin Pract Oncol. 2008 Nov;5(11):645-54. doi: 10.1038/ncponc1219. Epub 2008 Sep 9. Nat Clin Pract Oncol. 2008. PMID: 18779850 Review.

10

Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the Belgian multicentre study.

de Azambuja E, Paesmans M, Beauduin M, Vindevoghel A, Cornez N, Finet C, Ries F, Closon-Dejardin MT, Kerger J, Gobert P, Focan C, Tagnon A, Dolci S, Nogaret JM, di Leo A, Piccart-Gebhart MJ. de Azambuja E, et al. J Clin Oncol. 2009 Feb 10;27(5):720-5. doi: 10.1200/JCO.2008.17.2155. Epub 2008 Dec 22. J Clin Oncol. 2009. PMID: 19103732 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

313 results

Search Page